These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1354669)

  • 1. Intravenous recombinant secretory leukoprotease inhibitor augments antineutrophil elastase defense.
    Birrer P; McElvaney NG; Gillissen A; Hoyt RF; Bloedow DC; Hubbard RC; Crystal RG
    J Appl Physiol (1985); 1992 Jul; 73(1):317-23. PubMed ID: 1354669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid.
    Gillissen A; Birrer P; McElvaney NG; Buhl R; Vogelmeier C; Hoyt RF; Hubbard RC; Crystal RG
    J Appl Physiol (1985); 1993 Aug; 75(2):825-32. PubMed ID: 7901193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
    Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG
    J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epithelium.
    Vogelmeier C; Buhl R; Hoyt RF; Wilson E; Fells GA; Hubbard RC; Schnebli HP; Thompson RC; Crystal RG
    J Appl Physiol (1985); 1990 Nov; 69(5):1843-8. PubMed ID: 2272977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis.
    McElvaney NG; Doujaiji B; Moan MJ; Burnham MR; Wu MC; Crystal RG
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1056-60. PubMed ID: 8105734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity.
    Vogelmeier C; Gillissen A; Buhl R
    Chest; 1996 Dec; 110(6 Suppl):261S-266S. PubMed ID: 8989162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.
    McElvaney NG; Nakamura H; Birrer P; Hébert CA; Wong WL; Alphonso M; Baker JB; Catalano MA; Crystal RG
    J Clin Invest; 1992 Oct; 90(4):1296-301. PubMed ID: 1357002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of native and oxidation-resistant secretory leukoprotease inhibitor on cystic fibrosis sputum: inhibition of neutrophil elastase activity and of sputum-induced secretion from porcine tracheal submucosal glands.
    Schuster A; Hansen G; Zubrod-Eichert C; Wahn V
    Pediatr Res; 1996 Nov; 40(5):732-7. PubMed ID: 8910939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific cleavage of secretory leukoprotease inhibitor by neutrophil elastase and saliva.
    Masuda K; Suga T; Takeuchi A; Kanesaki M; Imaizumi A; Suzuki Y
    Biochem Pharmacol; 1994 Aug; 48(4):651-7. PubMed ID: 8080437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and distribution of recombinant secretory leukocyte proteinase inhibitor in rats.
    Gast A; Anderson W; Probst A; Nick H; Thompson RC; Eisenberg SP; Schnebli H
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):889-94. PubMed ID: 2327652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
    Birrer P; McElvaney NG; Rüdeberg A; Sommer CW; Liechti-Gallati S; Kraemer R; Hubbard R; Crystal RG
    Am J Respir Crit Care Med; 1994 Jul; 150(1):207-13. PubMed ID: 7912987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretory leukoprotease inhibitor attenuates lung injury induced by continuous air embolization into sheep.
    Gossage JR; Perkett EA; Davidson JM; Starcher BC; Carmichael D; Brigham KL; Meyrick B
    J Appl Physiol (1985); 1995 Oct; 79(4):1163-72. PubMed ID: 8567558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation.
    Llewellyn-Jones CG; Lomas DA; Stockley RA
    Thorax; 1994 Jun; 49(6):567-72. PubMed ID: 7912452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory leukoprotease inhibitor: partnering alpha 1-proteinase inhibitor to combat pulmonary inflammation.
    Bingle L; Tetley TD
    Thorax; 1996 Dec; 51(12):1273-4. PubMed ID: 8994529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of secretory leukoprotease inhibitor in the human nasal airway.
    Lee CH; Igarashi Y; Hohman RJ; Kaulbach H; White MV; Kaliner MA
    Am Rev Respir Dis; 1993 Mar; 147(3):710-6. PubMed ID: 8095126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
    van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
    J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human secretory leukocyte-protease inhibitor: in vitro properties, and amelioration of human neutrophil elastase-induced emphysema and secretory cell metaplasia in the hamster.
    Lucey EC; Stone PJ; Ciccolella DE; Breuer R; Christensen TG; Thompson RC; Snider GL
    J Lab Clin Med; 1990 Feb; 115(2):224-32. PubMed ID: 2299266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.
    Renesto P; Balloy V; Kamimura T; Masuda K; Imaizumi A; Chignard M
    Br J Pharmacol; 1993 Apr; 108(4):1100-6. PubMed ID: 8097952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil elastase increases secretory leukocyte protease inhibitor transcript levels in airway epithelial cells.
    Abbinante-Nissen JM; Simpson LG; Leikauf GD
    Am J Physiol; 1993 Sep; 265(3 Pt 1):L286-92. PubMed ID: 8105697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative loss of activity of recombinant secretory leukoprotease inhibitor and alpha 1-protease inhibitor caused by different forms of oxidative stress.
    Vogelmeier C; Biedermann T; Maier K; Mazur G; Behr J; Krombach F; Buhl R
    Eur Respir J; 1997 Sep; 10(9):2114-9. PubMed ID: 9311513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.